drug
Why we need to improve transparency in the pharmaceutical supply chain
June 28 by Pharma Logistics EditorHow changes in the industry may end up benefiting drug prices and transparency
It’s still business as usual: FDA’s proposed DSCSA enforcement delay
July 14 by Pharma Logistics EditorThe FDA has published draft guidance proposing a 12 month grace period on the enforcement of November’s DSCSA requirements. Even still the industry should continue serialization projects to secure su...
Innovation in Clinical Trial Supply
October 29 by Pharma Logistics EditorInnovation is thought to be a keystone in the process of being competitive in any market. Within clinical trial supply, a lack of innovation can be costly in regards to a range of variables.With this...
Logistics Becomes The Rising Star In Pharma
August 25 by Nitin DahadPharmaceutical product development is changing. The need to produce significantly higher potency large molecule biopharmaceutical drugs to improve efficacy and tailor drugs to the individual needs of...